AfricaNews: Over 200,000 people given Merck Ebola vaccine – DRC govt

In the Democratic Republic of the Congo (DRC), health workers and authorities have vaccinated over 200,000 people with the developing Ebola vaccine, named V920 and produced by Merck & Co Inc. Developing the Ebola vaccine has been further motivated by the ongoing outbreak in DRC and the vaccine’s potential role in combating the outbreak. Just recently, the U.S. Department of Health and Human Services announced its continued and increased funding to Merck & Co. for vaccine development.

To read the full article published in AfricaNews, click here.